Ligand validation:6F9R

PE8: 3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6F9R_PE8_B_721	56%	76%	0.117	0.888	0.52	0.42	-	-	1	0	100%	1
9H1B_PE8_B_702	42%	92%	0.136	0.852	0.28	0.23	-	-	0	0	100%	1
7Q26_PE8_B_704	23%	84%	0.167	0.787	0.54	0.23	-	-	0	0	100%	1
3L9V_PE8_A_1	98%	37%	0.063	0.982	0.59	1.85	-	7	3	0	100%	1
9KG9_PE8_A_303	84%	93%	0.092	0.955	0.19	0.28	-	-	0	0	100%	1
9JZ2_PE8_A_303	80%	95%	0.095	0.944	0.17	0.24	-	-	1	0	100%	1
9KXI_PE8_A_302	79%	95%	0.097	0.942	0.16	0.23	-	-	0	0	100%	1
9V92_PE8_A_302	78%	95%	0.093	0.934	0.14	0.26	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.